KalVista Pharmaceuticals
KALV
KALV
63 hedge funds and large institutions have $203M invested in KalVista Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
13% less funds holding
Funds holding: 72 → 63 (-9)
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Holders
63
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$7.06M | |
| 2 | +$1.54M | |
| 3 | +$1.52M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$779K |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$351K |
Top Sellers
| 1 | -$3.31M | |
| 2 | -$1.16M | |
| 3 | -$1.06M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$905K |
| 5 |
Renaissance Technologies
New York
|
-$500K |